Search filters
Termination TerugBetaalRegeling Forxiga® - Hartfalen

Termination TerugBetaalRegeling Forxiga® - Hartfalen

30/06/2021

From July 1st 2021 onwards, Forxiga® (dapagliflozine) 10 mg for the treatment of heart failure with reduced ejection fraction...

Amendment to TerugBetaalRegeling Lokelma®

Amendment to TerugBetaalRegeling Lokelma®

19/05/2021

TBR Nederland hereby informs you that it will make a change to a repayment scheme starting from now. This concerns the medicine...

Reimbursement Scheme FRAGMIN® 2500

Reimbursement Scheme FRAGMIN® 2500

28/01/2021

The health insurer does not fully reimburse FRAGMIN® 2500. The producer of this medicine has therefore asked TBR Nederland to...

Simplified TerugBetaalRegeling Broxil®

Simplified TerugBetaalRegeling Broxil®

31/12/2020

The health insurer will not reimburse the cost of Broxil® 125 mg / 5 mL, powder for oral suspension in full. The producer of this...

Reimbursement Scheme Zeposia®

Reimbursement Scheme Zeposia®

26/11/2020

The health insurer does not fully reimburse Zeposia® (0,23mg+0,46mg en 0,92mg). The producer of this medicine has therefore asked...

You are currently offline. Some pages or content may fail to load.